NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
NanoSyrinx has raised $13.1M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
NanoSyrinx's investors include Octopus Ventures, Eli Lilly, Business Growth Fund, IQ Capital, Future Planet Capital.
NanoSyrinx is headquartered in Coventry, United Kingdom.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
NanoSyrinx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NanoSyrinx — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/nanosyrinx. Accessed September 6, 2026.
VCBacked. (2024). NanoSyrinx — Funding & Investors. Retrieved September 6, 2026, from https://www.vcbacked.co/company/nanosyrinx
{{cite web |title=NanoSyrinx — Funding & Investors |url=https://www.vcbacked.co/company/nanosyrinx |website=VCBacked |access-date=September 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated